Abstract
Retracted: Identifying and Verifying AR, ERBB2, and VEGFA Are the Targets of Qigesan in the Treatment of Esophageal Adenocarcinoma In Silico and In Vitro
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have